Differences in the frequency of the DRB1*15 allelic group (MS) and the DRB1*03 allelic group (associated with NMO) were investigated in these eight populations, as illustrated in Fig. 3. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.